Gilead Sciences's total assets for Q2 2024 were $53.58B, a decrease of -4.82% from the previous quarter. GILD total liabilities were $35.38B for the fiscal quarter, a -8.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.